Healthline
January 17, 2025
Share on PinterestRed dye No. 3 has been shown in animal studies to cause cancer. JurgaR/Getty Images The FDA issued a ban on the use of […]
January 17, 2025
Share on PinterestWhile overall cancer deaths are declining, a new report shows that cancer incidence is increasing in females and young people. Mariano Garcia Gaspar/Getty Images […]
January 16, 2025
Share on PinterestRed dye No. 3 has been shown in animal studies to cause cancer. JurgaR/Getty Images The FDA issued a ban on the use of […]
January 15, 2025
Share on PinterestProcessed red meat consumption is linked to a 13% higher risk of dementia, a new study found. DigiPub/Getty Images Dementia cases in the U.S. […]
Medscape
February 20, 2025
In the final days of 2024, three pharmaceutical giants sued the federal government. In their joint lawsuit, Amgen, Eli Lilly and Company, and UCB claim several […]
February 20, 2025
Transdermal estradiol patches — the same ones used to curb menopause symptoms in women — are an effective alternative to luteinizing hormone–releasing hormone agonists to lower […]
February 20, 2025
(Reuters) – Some U.S. Food and Drug Administration scientists have been told to stop using the words “woman,” “disabled” and “elderly” in external communications, two sources […]
February 20, 2025
Dupilumab has been accepted for priority review by the US Food and Drug Administration (FDA) for the treatment of bullous pemphigoid (BP) in adults, according to […]
FDA
February 18, 2025
Delivery Method: Via Email Reference #: 320-25-39 Product: Drugs Recipient: Recipient Name Mr. Manish Gupta Recipient Title Managing Director Jagsonpal Pharmaceuticals Limited Plot No. 412-415, Phase-IVUdyog […]
February 18, 2025
Delivery Method: VIA Electronic Mail Reference #: 320-25-43 Product: Drugs Recipient: Recipient Name Mr. Vick Maharaj Recipient Title Chief Executive Officer Marshalls Traditional Healthcare CC 560 […]
February 14, 2025
On February 14, 2025, the Food and Drug Administration approved vimseltinib (Romvimza, Deciphera Pharmaceuticals, LLC), a kinase inhibitor, for adult patients with symptomatic tenosynovial giant cell […]
February 14, 2025
For Immediate Release: February 14, 2025 Today, the U.S. Food and Drug Administration approved Merilog (insulin-aspart-szjj) as biosimilar to Novolog (insulin aspart) for the improvement of […]
